Lepu Biopharma Co Ltd
HKEX:2157
Income Statement
Earnings Waterfall
Lepu Biopharma Co Ltd
Revenue
|
225.4m
CNY
|
Cost of Revenue
|
-28.3m
CNY
|
Gross Profit
|
197.1m
CNY
|
Operating Expenses
|
-412.5m
CNY
|
Operating Income
|
-215.5m
CNY
|
Other Expenses
|
193.4m
CNY
|
Net Income
|
-22.1m
CNY
|
Income Statement
Lepu Biopharma Co Ltd
Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
16
N/A
|
169
+986%
|
225
+33%
|
|
Gross Profit | ||||
Cost of Revenue |
(2)
|
(8)
|
(28)
|
|
Gross Profit |
14
N/A
|
161
+1 089%
|
197
+22%
|
|
Operating Income | ||||
Operating Expenses |
(719)
|
(613)
|
(413)
|
|
Selling, General & Administrative |
(124)
|
(109)
|
(130)
|
|
Research & Development |
(463)
|
(525)
|
(458)
|
|
Depreciation & Amortization |
(78)
|
0
|
0
|
|
Other Operating Expenses |
(54)
|
21
|
175
|
|
Operating Income |
(705)
N/A
|
(452)
+36%
|
(215)
+52%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
6
|
(40)
|
185
|
|
Non-Reccuring Items |
1
|
0
|
0
|
|
Total Other Income |
(1)
|
(1)
|
0
|
|
Pre-Tax Income |
(699)
N/A
|
(493)
+30%
|
(30)
+94%
|
|
Net Income | ||||
Tax Provision |
0
|
0
|
0
|
|
Income from Continuing Operations |
(699)
|
(493)
|
(30)
|
|
Income to Minority Interest |
10
|
6
|
8
|
|
Net Income (Common) |
(689)
N/A
|
(487)
+29%
|
(22)
+95%
|
|
EPS (Diluted) |
-0.42
N/A
|
-0.29
+31%
|
-0.01
+97%
|